In The News

In The News

Multiple Sclerosis News Today | October 12, 2018
By Jose Marques Lopez, PhD
PharmaVOICE
Enjoyed discussing the future of  cancer care and the role biomarkers will play in advancing less invasive detection options, more accurate diagnoses and more personalized treatment pathways with PharmaVOICE.
Forbes | September 22, 2018
By Tom Taulli | Contributor
September 25, 2018
In a recent interview with Baystate Business, Kevin Hrusovsky, Quanterix Chairman and CEO and founder of Powering Precision Health, explains the fundamentals of Quanterix technology and how it's disrupting the way healthcare is practiced.  Click the file below to hear the interview.
Digital Biotech | September 07, 2018
Kevin Hrusovsky, Quanterix Chairman and CEO and Founder of Powering Precision Health, recently sat down with TetraScience CEO Alok Tayi to talk about the exciting work that Quanterix is doing in the area of clinical biomarkers and the business of diagnostics, as well as healthcare, more broadly,
Practical Neurology | September 05, 2018
A roundtable discussion with Chase Spurlock, PhD, IQuity; Michal Izrael, PhD, Kadimastem Ltd; Kevin Hrusovsky, Quanterix; and J. Michael Ryan, MD, Rodin Therapeutics
Washington Report | September 04, 2018
By: Kevin Hrusovsky
ALZFORUM.ORG | August 24, 2018
A lot can happen in a year.